Synthesizing 768 oligos just got faster with Dr. Oligo 768XLc        The Dr. Oligo 768XLc high throughput oligo synthesizer is Biolyticʻs fastest synthesizer yet FREMONT, California –  Biolytic Lab Performance Inc. unveiled its novel oligo synthesizer, the Dr. Oligo 768XLc, the most commercially advanced platform for high throughput nucleic acid synthesis. Designed to be operated [...]

New structure to enhance company’s focus on customers, disruptive innovation, and growth; Chief operating officer to drive operational excellence CORNING, N.Y. -- Corning Incorporated announced on Wednesday that it is reorganizing its operating structure based on extensive analysis and leadership review. The new structure aligns executive management and business teams around five Market-Access Platforms (MAPs): [...]

DeNovix Inc. expands its fluorescence quantification range with the introduction of the new DeNovix RNA Assay. WILMINGTON, DE – DeNovix Inc., a developer and manufacturer of instrumentation and assays for the life sciences, introduces a new RNA fluorescence quantification assay. The assay is suitable for multiple platforms including stand-alone fluorometers, plate readers or any DeNovix [...]

LAUSANNE, Switzerland and BOSTON -- SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Lara Hashimoto has joined its Executive Team as Chief Business Officer, effective April 1st. She will be responsible for Marketing, Product Management and Business Development. Lara Hashimoto joined the healthcare industry 20 years ago holding several leadership roles spanning Pharma clinical drug development, sales and marketing before moving to Roche [...]

Collaboration on Novel iCIEF-MS Platform speeds up critical decisions and streamlines approaches in biopharma environment SCIEX, a global leader in life science analytical technologies, and Intabio, a developer of innovative instrumentation systems for biotherapeutic precision analysis and quality assessment, announced a collaboration to couple Intabio's Blaze™ system with SCIEX high resolution accurate mass (HRAM) systems. This [...]

LabCorp, UC San Diego and the National Institute of Allergy and Infectious Diseases are among the organizations utilizing PacBio’s highly accurate long-read sequencing technology to study SARS-CoV-2 and the related immune response to COVID-19 MENLO PARK, Calif. -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced [...]

MAHWAH, NJ, April 8, 2020 – EDAX, Inc., a leader in X-ray microanalysis and electron diffraction instrumentation, has signed a distributor agreement with Angstrom Scientific. The agreement allows Angstrom Scientific to sell all EDAX products in the United States. “We are excited to welcome Angstrom Scientific to the EDAX sales team,” said EDAX U.S. Sales Manager, [...]

Appointment brings significant Board and commercial experience to deliver sustainable company growth Borehamwood, UK: H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety and scale-up, today announced the appointment of Kevin O’Donovan as Chair of the H.E.L Board of Directors. Kevin takes over from interim Chair, Jon Andrew, and [...]

SAN DIEGO -- Organovo Holdings, Inc. (“Organovo”) (Nasdaq: ONVO) announced today that it has terminated the merger agreement with Tarveda Therapeutics, Inc. (“Tarveda”), originally announced on December 16, 2019, and will continue to operate as an independent company. The Company had submitted the merger proposal and other related proposals to be voted upon at a Special Meeting of Stockholders, as described [...]

— Unanticipated late opposition by major Organovo stockholder results in termination of proposed merger agreement — — Tarveda continues advancement of current Pentarin® miniature drug conjugate clinical programs towards key clinical milestones — Watertown, MA – Tarveda Therapeutics, Inc. (“Tarveda”), a clinical stage biopharmaceutical company developing a new class of potent and selective precision oncology medicines, which it [...]